文献速递哮喘

防螨床罩预防儿童重症哮喘发作的随机试验

Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

该随机对照试验纳入3-17岁因哮喘急性发作急诊就诊的尘螨致敏哮喘患儿,比较防螨床罩与对照床罩在12个月内对重症哮喘发作的影响。结果显示防螨床罩组因急性发作急诊就诊的患儿比例显著低于对照组,多变量分析中急诊就诊风险降低45%,但口服泼尼松使用风险无差异。

要点

  • 防螨床罩可减少尘螨致敏哮喘患儿因急性发作急诊就诊的比例
  • 多变量分析显示急诊就诊风险降低45%(HR 0.55,95%CI 0.36-0.85)
  • 两组口服泼尼松使用风险无显著差异

核心结论

  • 防螨床罩可有效减少尘螨致敏哮喘患儿因哮喘急性发作急诊就诊的人数,但不能减少需要口服泼尼松的人数。

研究设计与样本

  • 随机对照试验,纳入3-17岁尘螨致敏哮喘患儿,在因哮喘急性发作急诊就诊后随机分为防螨床罩组(146例)和对照床罩组(138例),干预12个月。

主要发现

  • 12个月时,防螨床罩组因急性发作急诊就诊的患儿为36/123(29.3%),对照组为49/118(41.5%),P=0.047。
  • 多变量分析中,防螨床罩组急诊就诊风险较对照组降低45%(HR 0.55,95%CI 0.36-0.85,P=0.006)。
  • 防螨床罩组因急性发作急诊就诊的年发生率较对照组低27%,但未达统计学显著性(估计边际均值:防螨组0.38,95%CI 0.26-0.56;对照组0.52,95%CI 0.35-0.76;P=0.18)。
  • 两组因急性发作使用泼尼松的风险无差异(HR 0.82,95%CI 0.58-1.17,P=0.28)。

临床怎么用

  • 对于尘螨致敏的哮喘患儿,防螨床罩可作为减少因急性发作急诊就诊的简单辅助措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Allergen exposure in sensitized individuals with asthma interacts with viruses to increase the risk of asthma exacerbation. OBJECTIVES: To evaluate the use of house dust mite-impermeable bedding and its impact on severe asthma exacerbations in children. METHODS: We randomized mite-sensitized children with asthma (ages 3-17 yr) after an emergency hospital attendance with an asthma exacerbation to receive mite-impermeable (active group) or control (placebo group) bed encasings. MEASUREMENTS AND MAIN RESULTS: Over a 12-month intervention period, the occurrence of severe asthma exacerbations was investigated. Of 434 children with asthma who consented, 286 (mean age, 7.7 yr; male sex, 65.8%) were mite sensitized, and 284 were randomized (146 to the active group and 138 to the placebo group). At 12 months, significantly fewer children in the active group than in the placebo group had attended the hospital with an exacerbation (36 [29.3%] of 123 vs. 49 [41.5%] of 118; P = 0.047). In the multivariable analysis, the risk of emergency hospital attendance was 45% lower in the active group (hazard ratio, 0.55; 95% confidence interval [CI], 0.36-0.85; P = 0.006) than in the placebo group. The annual rate of emergency hospital attendance with exacerbations was 27% lower in the active group than in the placebo group, but this did not reach significance (estimated marginal mean [95% CI], active, 0.38 [0.26-0.56] vs. placebo, 0.52 [0.35-0.76]; P = 0.18). No difference between the groups in the risk of prednisolone use for exacerbation was found (hazard ratio, 0.82; 95% CI, 0.58-1.17; P = 0.28). CONCLUSIONS: Mite-impermeable encasings are effective in reducing the number of mite-sensitized children with asthma attending the hospital with asthma exacerbations but not the number requiring oral prednisolone. This simple measure may reduce the health care burden of asthma exacerbations in children. Clinical trial registered with www.isrctn.com (ISRCTN 69543196).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Murray CS, Foden P, Sumner H, et al. Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers. Am J Respir Crit Care Med. 2017. PMID: 28282501. doi:10.1164/rccm.201609-1966OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。